The standard Breast Cancer Risk Assessment Tool currently used by physicians to calculate an individual's risk for developing breast cancer is often referred to as the Gail Model. While effective for most, this model does not take into account the risk of ovarian cancer and only looks at first-degree relativesí medical history, making it less effective for identifying women whose family cancer histories suggest a risk for hereditary breast cancer syndrom.
Only two or three percent of breast cancers are known to be the result of hereditary mutations. The most commonly recognized of these mutated breast cancer genes are BRCA1 and BRCA2. Inheritance leads to an approximately 80 percent lifetime risk of developing breast cancer, making the PAT test a potential lifesaver for affected individuals.